Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Glampson, B"'
Autor:
Kallis C, Kaura A, Samuel NA, Mulla A, Glampson B, O'Gallagher K, Davies J, Papadimitriou D, Woods KJ, Shah AD, Williams B, Asselbergs FW, Mayer EK, Lee RW, Herbert C, Grant SW, Curzen N, Squire IB, Johnson T, Shah AM, Perera D, Kharbanda RK, Patel RS, Channon KM, Mayet J, Quint JK
Publikováno v:
International Journal of COPD, Vol Volume 18, Pp 2405-2416 (2023)
Constantinos Kallis,1– 3 Amit Kaura,1,3 Nathan A Samuel,4 Abdulrahim Mulla,3 Ben Glampson,3 Kevin O’Gallagher,5 Jim Davies,4 Dimitri Papadimitriou,3 Kerrie J Woods,4 Anoop D Shah,6,7 Bryan Williams,6,7 Folkert W Asselbergs,6,7 Erik K Mayer,3,8 Ri
Externí odkaz:
https://doaj.org/article/7b7768fb9a8e4a7dbdfd219b11b14dbd
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ruan, Y, Mercuri, L, Papadimitriou, D, Galdikas, A, Roadknight, G, Davies, J, Glampson, B, Mayer, E, Hill, NE, Rea, R
Publikováno v:
Journal of Diabetes and its Complications. 37:108474
BACKGROUND: We used detailed information on patients with diabetes admitted to hospital to determine differences in clinical outcomes before and during the COVID-19 pandemic in the UK. METHODS: The study used electronic patient record data from Imper
Summary report on the views of members of the public on using Artificial intelligence as part of building the digital healthcare programme of research in North West London.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d7bd12ad44de85fa6e2b1f51317b0ed
A summary of the insights gathered from a public involvement discussion involving patients and cares with lived experience of ovarian cancer and their views on a health data project “Innovative, automated use of real-world healthcare data to improv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a1008c0ea00bc01275c4378fdd25e59
Autor:
Espinosa-Gonzalez, A, Prociuk, D, Fiorentino, F, Ramtale, C, Mi, E, Glampson, B, Neves, AL, Okusi, C, Hussain, L, Macartney, J, Brown, M, Browne, B, Warren, C, Chowla, R, Heaversedge, J, Greenhalgh, T, De Lusignan, S, Mayer, E, Delaney, B
BackgroundAccurate assessment of COVID-19 severity in the community is essential for best patient care and efficient use of services and requires a risk prediction score that is COVID-19 specific and adequately validated in a community setting. Follo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::85cab38a432ff820f96850dce7df8ea2
http://hdl.handle.net/10044/1/97723
http://hdl.handle.net/10044/1/97723
Autor:
Honeyford, K, Expert, P, Mendelsohn, EE, Post, B, Faisal, AA, Glampson, B, Mayer, EK, Costelloe, CE
Publikováno v:
Frontiers in digital health. 4
Harnessing Real World Data is vital to improve health care in the 21st Century. Data from Electronic Health Records (EHRs) are a rich source of patient centred data, including information on the patient's clinical condition, laboratory results, diagn
Autor:
Sau, A, Kaura, A, Ahmed, A, Patel, KHK, Li, X, Mulla, A, Glampson, B, Panoulas, V, Davies, J, Woods, K, Gautama, S, Shah, AD, Elliott, P, Hemingway, H, Williams, B, Asselbergs, FW, Melikian, N, Peters, NS, Shah, AM, Perera, D, Kharbanda, R, Patel, RS, Channon, KM, Mayet, J, Ng, FS
Publikováno v:
Journal of the American Heart Association. 11
Background A minority of acute coronary syndrome (ACS) cases are associated with ventricular arrhythmias (VA) and/or cardiac arrest (CA). We investigated the effect of VA/CA at the time of ACS on long‐term outcomes. Methods and Results We analyzed
Autor:
Kaura, A, Hartley, A, Panoulas, V, Glampson, B, Shah, ASV, Davies, J, Mulla, A, Woods, K, Omigie, J, Shah, AD, Thursz, MR, Elliott, P, Hemmingway, H, Williams, B, Asselbergs, FW, O'Sullivan, M, Lord, GM, Trickey, A, Sterne, JA, Haskard, DO, Melikian, N, Francis, DP, Koenig, W, Shah, AM, Kharbanda, R, Perera, D, Patel, RS, Channon, KM, Mayet, J, Khamis, R
Publikováno v:
Kaura, A, Hartley, A, Panoulas, V, Glampson, B, Shah, A S V, Davies, J, Mulla, A, Woods, K, Omigie, J, Shah, A D, Thursz, M R, Elliott, P, Hemmingway, H, Williams, B, Asselbergs, F W, O'Sullivan, M, Lord, G M, Trickey, A, Sterne, J A, Haskard, D O, Melikian, N, Francis, D P, Koenig, W, Shah, A M, Kharbanda, R, Perera, D, Patel, R S, Channon, K M, Mayet, J & Khamis, R 2022, ' Mortality risk prediction of high-sensitivity C-reactive protein in suspected acute coronary syndrome : A cohort study ', PLoS Medicine, vol. 19, no. 2, e1003911, pp. e1003911 . https://doi.org/10.1371/journal.pmed.1003911
Kaura, A, Hartley, A, Panoulas, V, Glampson, B, Shah, A S V, Davies, J, Mulla, A, Woods, K, Omigie, J, Shah, A D, Thursz, M R, Elliott, P, Hemmingway, H, Williams, B, Asselbergs, F W, O'Sullivan, M, Lord, G M, Trickey, A, Sterne, J A, Haskard, D O, Melikian, N, Francis, D P, Koenig, W, Shah, A M, Kharbanda, R, Perera, D, Patel, R S, Channon, K M, Mayet, J & Khamis, R 2022, ' Mortality risk prediction of high-sensitivity C-reactive protein in suspected acute coronary syndrome : A cohort study ', PLoS Medicine, vol. 19, no. 2, e1003911 . https://doi.org/10.1371/journal.pmed.1003911
Kaura, A, Hartley, A, Panoulas, V, Glampson, B, Shah, A S V, Davies, J, Mulla, A, Woods, K, Omigie, J, Shah, A D, Thursz, M R, Elliott, P, Hemmingway, H, Williams, B, Asselbergs, F W, O'Sullivan, M, Lord, G M, Trickey, A, Sterne, J A, Haskard, D O, Melikian, N, Francis, D P, Koenig, W, Shah, A M, Kharbanda, R, Perera, D, Patel, R S, Channon, K M, Mayet, J & Khamis, R 2022, ' Mortality risk prediction of high-sensitivity C-reactive protein in suspected acute coronary syndrome : A cohort study ', PLoS Medicine, vol. 19, no. 2, e1003911 . https://doi.org/10.1371/journal.pmed.1003911
Funder: THIS Institute
BACKGROUND: There is limited evidence on the use of high-sensitivity C-reactive protein (hsCRP) as a biomarker for selecting patients for advanced cardiovascular (CV) therapies in the modern era. The prognostic value of mi
BACKGROUND: There is limited evidence on the use of high-sensitivity C-reactive protein (hsCRP) as a biomarker for selecting patients for advanced cardiovascular (CV) therapies in the modern era. The prognostic value of mi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82915bcff7d946b431b5f0a8b89d2ac4
https://www.repository.cam.ac.uk/handle/1810/335410
https://www.repository.cam.ac.uk/handle/1810/335410
Autor:
Benedetto, U, Sinha, S, Mulla, A, Glampson, B, Davies, J, Panoulas, V, Gautama, S, Papadimitriou, D, Woods, K, Elliott, P, Hemingway, H, Williams, B, Asselbergs, FW, Melikian, N, Krasopoulos, G, Sayeed, R, Wendler, O, Baig, K, Chukwuemeka, A, Angelini, GD, Sterne, JAC, Johnson, T, Shah, AM, Perera, D, Patel, RS, Kharbanda, R, Channon, KM, Mayet, J, Kaura, A
Publikováno v:
International journal of cardiology. 362
Implications of elevated troponin on time-to-surgery in non-ST elevation myocardial infarction(NIHR Health Informatics Collaborative:TROP-CABG study). Benedetto et al. BACKGROUND: The optimal timing of coronary artery bypass grafting (CABG) in patien